A Johns Hopkins Children's Center-led study shows that patients with spinal muscular atrophy (SMA) could regain muscle with the help of a new monoclonal antibody treatment.

Richard Tang-Wai, M.D., a pediatric neurologist and chief of epilepsy, joined Johns Hopkins All Children's Hough Family Institute for Brain Protection Sciences in August 2025.

Valerie Martínez-Torres, M.D., a bilingual pediatric hematology-oncology specialist, joined Johns Hopkins All Children' in July 2025.

A longitudinal study at Johns Hopkins depends on the dedication of hundreds of people.

Henry Brem reflects on his time leading the Johns Hopkins Department of Neurosurgery.

A blood test approved by the Food and Drug Administration in May provides an inexpensive and noninvasive way to detect biomarkers of Alzheimer’s disease, vastly increasing opportunities for early detection and treatment. This test was developed based on research completed at Johns Hopkins, Lund University and private companies.

Cardiologists provide customized care for a serious and complex condition with many nuances.

An individualized approach to monitoring patients who receive thrombolysis for acute ischemic stroke may improve patient satisfaction, reduce intensive care unit admissions, and lessen the burden on hospital staff.

Specialists from a variety of disciplines make up a world-class team at the Skull Base Tumor Center.

Cutting-edge technology offers significant advantages over conventional endoscopic approaches for surgeries such as lingual tonsillectomies.

Johns Hopkins rheumatologists work together to unravel the mysteries of the disease.

The combination of biomaterials engineering and AI-driven drug design offers promising solutions to some of the most pressing challenges in eye care.